Literature DB >> 16253548

Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in Plasma Preparation Tubes (PPT).

Brigitte P Griffith1, Donald R Mayo.   

Abstract

BACKGROUND: The accurate and reliable quantification of HIV RNA is an essential part of the management of HIV infected individuals, and elucidation of factors that may affect HIV RNA measurements, such as the use of Vacutainer Plasma Preparation Tubes (PPT), is crucial.
OBJECTIVES: The objective of this study was to determine if plasma samples with viral loads close to the lower limit of the dynamic range of the assay collected in PPT tubes had increased levels of HIV RNA as compared to samples collected in standard EDTA tubes. STUDY
DESIGN: HIV RNA levels were compared in 112 paired plasma samples collected in PPT and standard EDTA tubes. All samples had been frozen prior to testing.
RESULTS: Discrepancies between PPT and EDTA tubes did not occur for samples with high viral loads. However, in samples with viral loads close to the lower limit of the dynamic range, levels of HIV RNA detected were higher in a large proportion of PPT as compared to the corresponding EDTA plasma samples. Forty percent of plasma pairs had no detectable HIV RNA in the EDTA aliquot, but had low levels of HIV RNA in the corresponding PPT aliquot.
CONCLUSIONS: This prospective study underlines the need for cautious interpretation of small transient viral load changes in samples with values close to the detection limit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253548     DOI: 10.1016/j.jcv.2005.08.008

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  10 in total

1.  Performance of the Abbott RealTime HIV-1 viral load assay is not impacted by integrase inhibitor resistance-associated mutations.

Authors:  Thomas P Young; Gavin Cloherty; Signe Fransen; Laura Napolitano; Priscilla Swanson; Christine Herman; Neil T Parkin; John Hackett
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

2.  Evaluation of effect of specimen-handling parameters for plasma preparation tubes on viral load measurements obtained by using the Abbott RealTime HIV-1 load assay.

Authors:  Helen Fernandes; Svetlana Morosyuk; Klara Abravaya; Madhuri Ramanathan; Lynne Rainen
Journal:  J Clin Microbiol       Date:  2010-05-19       Impact factor: 5.948

3.  Coamplification of HIV-1 proviral DNA and viral RNA in assays used for quantification of HIV-1 RNA.

Authors:  H Wan; A Seth; L Rainen; H Fernandes
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

4.  Successful use of Plasma Preparation Tubes™ (PPTs) in the COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 test.

Authors:  Colleen S Kraft; José Nilo G Binongo; Eileen M Burd; Molly E Eaton; Cindy B McCloskey; Helen Fernandes; Charles E Hill; Angela M Caliendo
Journal:  J Clin Virol       Date:  2013-01-16       Impact factor: 3.168

5.  Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes.

Authors:  Anne-Marte Bakken Kran; Tom Øystein Jonassen; Mette Sannes; Kirsti Jakobsen; Andreas Lind; Arild Maeland; Mona Holberg-Petersen
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

6.  Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays.

Authors:  Lesley E Scott; Lara D Noble; Jackie Moloi; Linda Erasmus; Willem D F Venter; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

7.  Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures.

Authors:  Peter F Rebeiro; Asghar Kheshti; Sally S Bebawy; Samuel E Stinnette; Husamettin Erdem; Yi-Wei Tang; Timothy R Sterling; Stephen P Raffanti; Richard T D'Aquila
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

8.  Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.

Authors:  Ninon Taylor; Katharina Grabmeier-Pfistershammer; Alexander Egle; Richard Greil; Armin Rieger; Bruno Ledergerber; Hannes Oberkofler
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

9.  Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study.

Authors:  Gisela Leierer; Katharina Grabmeier-Pfistershammer; Andrea Steuer; Maria Geit; Mario Sarcletti; Bernhard Haas; Manfred Kanatschnig; Michaela Rappold; Robert Zangerle; Bruno Ledergerber; Ninon Taylor
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

10.  Systematic review of the accuracy of plasma preparation tubes for HIV viral load testing.

Authors:  Robert Luo; Jessica Markby; Jilian Sacks; Lara Vojnov
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.